|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacokinetic comparison of an angiotensin Ⅱ receptor antagonist, telmisartan, in Japanese and western hypertensive patients using population pharmacokinetic method 显示文摘 | Tatami S Yamamura N Sarashina A | 2004 | Drug Metab Pharmacokinet2004，19，： | 1 |
| 2 | Linagliptin, a dipeptidyl peptidase- 4 inhibitor in development for the treatment of type 2 diabetes mellitus: a phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects 显示文摘 | SARASHINA A SESOKO S NAKASHIMA M et ol | 2010 | Clin Ther2010，32，6： | 1 |
| 3 | Population pharmacokinetics of an angiotensinⅡ receptor antagonist, telmisartan, in healthy volunteers and hypertensive patients显示文摘 | Tatami S Sarashina A Yamamura N Igarashi T Tanigawara Y | 2003 | Drug Metab Pharmacokinet2003，18，3： | 1 |
| 4 | Pharmacokinetic comparison of an angiotensinⅡ receptor antagonist, telmisartan, in Japanese and western hypertensive patients using population pharmacokinetic method显示文摘 | Tatami S Yamamura N Sarashina A Yong CL Igarashi T Tanigawara Y | 2004 | Drug Metab Pharmacokinet2004，19，1： | 1 |
| 5 | Population pharmacokinetics of epinastine,a histamine H1 receptor antagonist,in adults and children显示文摘 | Sarashina A Tatami S Yamamura N | 2005 | Br J Clin Pharmacol2005，59，： | 1 |
| 6 | Pharmacokinetic comparison of an angitensin receptor antagonist, telmisartan, in Japanese and Western hypertensive patients using population pharmacokinetic method 显示文摘 | TATAMI S YAMAMURA N SARASHINA A | 2004 | Drug Metab Pharmacokin2004，19，1： | 1 |
| 7 | Risk factor analysis of bloodstream infection in pediatric patients after hematopoietic stem cell transplantation显示文摘 | Sarashina T Yoshida M Iguchi A | 2013 | J Pediatr Hematol Oncol2013，35，1： | 1 |
| 8 | Safety, tolerability, pharmacokinetics and pharmacodynam- ics of single doses of empagliflozin, a sodium glu- cose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects 显示文摘 | Sarashina A Koiwai K Seman L J | 2013 | Drug Metab Pharmacokinet2013，28，3： | 1 |
| 9 | Safety, tolerability, pharmacokinetics and pharmacodynam- ies of single doses of empagliflozin, a sodium glu- cose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects 显示文摘 | Sarashina A Koiwai K Seman L J | 2013 | Drug Metab Pharmacokinet2013，28，3： | 1 |
| 10 | Population pharmaco- kinetics of an angiotensin II receptor antagonist, telmisartan, in healthy volunteers and hypertensive patients 显示文摘 | Tatami S Sarashina A Yamamura N | 2003 | Drug Metab Pharmacokinet2003，18，3： | 1 |
| 11 | Population pharmacokinetics of epinastine,a histamine H1 receptor antagonist,in adults and children显示文摘 | Sarashina A Tatami S Yamamura N | 2005 | Br J Clin Pharmacol2005，59，： | 1 |
| 12 | Safety, tolerability, pharmaeokinetics and pharmaeodynamies of single doses of em- pagliflozin, a sodium glucose eotransporter 2 (SGLT2) Inhibi- tor, in healthy Japanese subjects 显示文摘 | Sarashina A Koiwai K Seman LJ | 2013 | Drug Metab Pharmacoki- net2013，28，3： | 1 |
| 13 | Safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects 显示文摘 | Sarashina A Koiwai K Seman L J | 2013 | Drug Metab Pharmacokinet2013，28，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员